Concepedia

Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial

Régis Peffault de Latour, Jeff Szer, Ilene C. Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, Kensuke Usuki, Morag Griffin, Jean‐Jacques Kiladjian, Carlos M. de Castro,

The Lancet Haematology · 2022 · 71 citations · 20 references

DOI

Concepts

References

20

Fatigue in cancer patients compared with fatigue in the general United States population

David Cella, Jin‐Shei Lai, Chih‐Hung Chang et al. · Cancer · 2002 · 845 citations · Full text

, , +11

Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales

David Cella, David T. Eton, Jin‐Shei Lai et al. · Journal of Pain and Symptom Management · 2002 · 810 citations

, , +11

The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.

David Cella · PubMed · 1997 · 691 citations

, , +13

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli et al. · Blood · 2007 · 653 citations

, , +11

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

Richard Kelly, Anita Hill, Louise Arnold et al. · Blood · 2011 · 516 citations · Full text

, , +5